Literature DB >> 25809766

Tuberculosis control in prisons: current situation and research gaps.

Masoud Dara1, Colleen D Acosta2, Natalie V S Vinkeles Melchers3, Haider A A Al-Darraji4, Dato Chorgoliani5, Hernan Reyes6, Rosella Centis7, Giovanni Sotgiu8, Lia D'Ambrosio7, Sarabjit S Chadha9, Giovanni Battista Migliori7.   

Abstract

BACKGROUND: Tuberculosis (TB) in penitentiary services (prisons) is a major challenge to TB control. This review article describes the challenges that prison systems encounter in TB control and provides solutions for the more efficient use of limited resources based on the three pillars of the post-2015 End TB Strategy. This paper also proposes research priorities for TB control in prisons based on current challenges.
METHODS: Articles (published up to 2011) included in a recent systematic review on TB control in prisons were further reviewed. In addition, relevant articles in English (published 1990 to May 2014) were identified by searching keywords in PubMed and Google Scholar. Article bibliographies and conference abstracts were also hand-searched.
RESULTS: Despite being a serious cause of morbidity and mortality among incarcerated populations, many prison systems encounter a variety of challenges that hinder TB control. These include, but are not limited to, insufficient laboratory capacity and diagnostic tools, interrupted supply of medicines, weak integration between civilian and prison TB services, inadequate infection control measures, and low policy priority for prison healthcare.
CONCLUSIONS: Governmental commitment, partnerships, and sustained financing are needed in order to facilitate improvements in TB control in prisons, which will translate to the wider community.
Copyright © 2015 World Health Organization. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  End TB Strategy; MDR-TB; Prisons; Research; Tuberculosis; Xpert MTB/RIF

Mesh:

Year:  2015        PMID: 25809766     DOI: 10.1016/j.ijid.2014.12.029

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  40 in total

1.  Addressing deprivation of liberty, human mobility and tuberculosis in 2018.

Authors:  Isabela Barbosa; Anna Versfeld; Khalid Tinasti; Assel Terlikbayeva
Journal:  Public Health Action       Date:  2017-12-21

2.  Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.

Authors:  L T Daum; O S Konstantynovska; O S Solodiankin; O O Liashenko; P I Poteiko; V I Bolotin; I I Hrek; A V Rohozhyn; J D Rodriguez; G W Fischer; J P Chambers; A P Gerilovych
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

3.  Drug-susceptible tuberculosis treatment outcomes and its associated factors among inmates in prison settings in Bauchi State, Nigeria, 2014-2018.

Authors:  Peter Okpeh Amede; Elizabeth Adedire; Aishat Usman; Celestine Attah Ameh; Faruk Saleh Umar; Chukwuma David Umeokonkwo; Muhammad Shakir Balogun
Journal:  PLoS One       Date:  2022-07-05       Impact factor: 3.752

4.  Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons.

Authors:  Paulo César Pereira Dos Santos; Andrea da Silva Santos; Roberto Dias de Oliveira; Bruna Oliveira da Silva; Thiego Ramon Soares; Leonardo Martinez; Renu Verma; Jason R Andrews; Julio Croda
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999

Review 5.  Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.

Authors:  Josiah D Rich; Curt G Beckwith; Alexandria Macmadu; Brandon D L Marshall; Lauren Brinkley-Rubinstein; Joseph J Amon; M-J Milloy; Maximilian R F King; Jorge Sanchez; Lukoye Atwoli; Frederick L Altice
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

Review 6.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

7.  Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013-2018.

Authors:  Khasan Safaev; Nargiza Parpieva; Irina Liverko; Sharofiddin Yuldashev; Kostyantyn Dumchev; Jamshid Gadoev; Oleksandr Korotych; Anthony D Harries
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

8.  Delivery of TB preventive therapy to incarcerated people living with HIV in southern African correctional facilities.

Authors:  L Chimoyi; H Smith; H Hausler; K Fielding; C J Hoffmann; M E Herce; S Charalambous
Journal:  Public Health Action       Date:  2021-12-21

9.  Negative latent tuberculosis at time of incarceration: identifying a very high-risk group for infection.

Authors:  L Arroyave; Y Keynan; L López; D Marin; M P Arbeláez; Z V Rueda
Journal:  Epidemiol Infect       Date:  2017-07-31       Impact factor: 4.434

10.  Incidence and Risk Factors Associated with Latent Tuberculosis Infection and Pulmonary Tuberculosis among People Deprived of Liberty in Colombian Prisons.

Authors:  Mariana Herrera; Yoav Keynan; Lucelly López; Diana Marín; Luisa Arroyave; María Patricia Arbeláez; Lázaro Vélez; Zulma Vanessa Rueda
Journal:  Am J Trop Med Hyg       Date:  2021-12-06       Impact factor: 3.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.